{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:19:14Z","timestamp":1760059154429,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The ACOSOG Z0011 and IBCSG 23-01 trials demonstrated that axillary lymph node dissection (ALND) offers no prognostic benefit in breast cancer patients with clinically negative axillae and low disease burden (one to two positive nodes) on sentinel lymph node biopsy (SLNB). However, uncertainty remains regarding the management of patients with clinically negative axillae (cN0) who are found to have suspicious lymph nodes on imaging that are subsequently confirmed positive by biopsy. The current practice often directs these patients to upfront ALND, potentially exposing them to unnecessary surgical morbidity. This study aimed to assess the role of axillary ultrasound in predicting high axillary nodal burden and guiding surgical management. Using the Alberta Cancer Registry, we identified 107 cN0 breast cancer patients from 2010 to 2017 who underwent preoperative axillary ultrasound with positive biopsy followed by ALND. Our findings reveal that 42% of these patients had low axillary nodal burden on final pathology, meeting Z0011 criteria, and might potentially have avoided ALND. Furthermore, axillary ultrasound findings were not predictive of high axillary burden. These results highlight that many patients undergoing upfront ALND based on positive ultrasound-guided biopsy could benefit from SLNB alone. This supports the 2023 NCCN guidelines advocating for more selective use of ALND to minimize overtreatment and associated morbidity.<\/jats:p>","DOI":"10.3390\/curroncol32060307","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:52:52Z","timestamp":1748325172000},"page":"307","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Axillary Ultrasound in the Era of Z0011: A Model for Predicting High Axillary Disease Burden"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6683-7300","authenticated-orcid":false,"given":"Ashley","family":"DiPasquale","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB T6G 2B7, Canada"},{"name":"Comprehensive Breast Center of Arizona, Phoenix, AZ 85016, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5692-3755","authenticated-orcid":false,"given":"Lashan","family":"Peiris","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB T6G 2B7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"unstructured":"Americain Cancer Society (2025, May 05). Cancer Facts & Figures 2025: American Cancer Statistics. Available online: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2025\/2025-cancer-facts-and-figures-acs.pdf.","key":"ref_1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1245\/ASO.2004.11.909","article-title":"NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial","volume":"11","author":"Krag","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-017-4405-3","article-title":"Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients","volume":"166","author":"Ahmed","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K","article-title":"Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma","volume":"88","author":"Schrenk","year":"2000","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7819-12-67","article-title":"Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients","volume":"12","author":"Soares","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/ejso.2002.1385","article-title":"Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy","volume":"29","author":"Schijven","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","article-title":"Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients","volume":"266","author":"Morrow","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2015.01.011","article-title":"Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: Management in the era of ACOSOG Z011","volume":"41","author":"Boland","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","article-title":"Predicting the extent of nodal disease in early-stage breast cancer","volume":"21","author":"Caudle","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.surg.2013.07.017","article-title":"Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer","volume":"154","author":"Hieken","year":"2013","journal-title":"Surgery"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ejso.2018.04.003","article-title":"Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result","volume":"44","author":"Lim","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"doi-asserted-by":"crossref","unstructured":"Liu, M., Yang, Y., Xie, F., Guo, J., Wang, S., Yang, H., and Wang, S. (2019). Could axillary clearance be avoided in clinically node-negative breast cancer patients with positive nodes diagnosed by ultrasound guided biopsy in the post-ACOSOG Z0011 era?. PLoS ONE, 14.","key":"ref_14","DOI":"10.1371\/journal.pone.0210437"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/dc.24203","article-title":"Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management","volume":"47","author":"Iwamoto","year":"2019","journal-title":"Diagn. Cytopathol."},{"unstructured":"(2025, May 05). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast Cancer, V.2.2.2023. Available online: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419.","key":"ref_16"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Panelists of the St Gallen Consensus Conference. Customizing local and systemic therapies for women with early breast cancer: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"SENOMAC Trialists\u2019 Group; SENOMAC Trialists\u2019 Group. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases","volume":"390","author":"Szulkin","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.breast.2023.03.005","article-title":"Tailored axillary surgery\u2014A novel concept for clinically node positive breast cancer","volume":"69","author":"Heidinger","year":"2023","journal-title":"Breast"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.annonc.2024.10.015","article-title":"A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive\/HER2-negative early breast cancer: Final invasive disease-free survival results from the NATALEE trial","volume":"36","author":"Hortobagyi","year":"2025","journal-title":"Ann. Oncol."},{"doi-asserted-by":"crossref","unstructured":"Le Boulc\u2019h, M., Gilhodes, J., Steinmeyer, Z., Moli\u00e8re, S., and Mathelin, C. (2021). Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET. J. Clin. Med., 10.","key":"ref_22","DOI":"10.3390\/jcm10071543"},{"doi-asserted-by":"crossref","unstructured":"Shao, H., Sun, Y., Na, Z., Jing, H., Li, B., Wang, Q., Zhang, C., and Cheng, W. (2024). Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: A study of 1247 patients. BMC Cancer, 24.","key":"ref_23","DOI":"10.1186\/s12885-024-11853-2"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Trial Group. Sentinel Lymph Node Biopsy vs. No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary Surgery in Breast Cancer\u2014Primary Results of the INSEMA Trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4048\/jbc.2019.22.e8","article-title":"Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy","volume":"22","author":"Lim","year":"2019","journal-title":"J. Breast Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/tbj.13479","article-title":"Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment?","volume":"26","author":"Liberale","year":"2020","journal-title":"Breast J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.eclinm.2022.101756","article-title":"INSEMA investigators. Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","volume":"55","author":"Reimer","year":"2022","journal-title":"eClinicalMedicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","article-title":"Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?","volume":"222","author":"Pilewskie","year":"2016","journal-title":"J. Am. Coll. Surg."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/6\/307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:41:05Z","timestamp":1760031665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/6\/307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["curroncol32060307"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32060307","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}